Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from animals and humans.

A global study uncovers the hidden role of viruses in driving bacterial evolution and highlights a surprising bacterial gene ...

The facility will be built to meet SFDA, FDA, EMA, and BMBL requirements and will include a fully integrated digital manufacturing platform.

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis" BOSTON, June 20 ...

A British man has just become the first-ever patient to receive a therapy dubbed the ‘world’s most expensive drug’ outside of ...

BCC Research announces the release of its "2024 Cell and Gene: Research Review," which forecasts strong and steady growth across several key areas of the cell and gene therapy (CGT) industry. This ...

The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

Beam Therapeutics shows promising BEACON trial results in SCD, backed by strong cash reserves and pipeline momentum. See why ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

And more pharma news updates from Pharmalittle.